South Carolina § 40-43-270 Limitations from liability and professional discipline.

South Carolina Statutes

§ 40-43-270 — Limitations from liability and professional discipline.

South Carolina § 40-43-270

Title 40PROFESSIONS AND OCCUPATIONS

Ch. 43SOUTH CAROLINA PHARMACY PRACTICE ACT

This text of South Carolina § 40-43-270 (Limitations from liability and professional discipline.) is published on Counsel Stack Legal Research, covering South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.C. Code Ann. § 40-43-270 (2026).

Text

(A)A prescriber who issues a standing prescription drug order in accordance with Section 40-43-260 is not liable for any civil damages for acts or omissions resulting from the dispensing of a self-administered hormonal contraceptive or the administering of an injectable hormonal contraceptive under this chapter.

(B)A pharmacist who dispenses a self-administered hormonal contraceptive or administers an injectable hormonal contraceptive in accordance with the provisions of this article is not as a result of an act or omission subject to civil or criminal liability or to professional disciplinary action.

Free access — add to your briefcase to read the full text and ask questions with AI

(A) A prescriber who issues a standing prescription drug order in accordance with Section 40-43-260 is not liable for any civil damages for acts or omissions resulting from the dispensing of a self-administered hormonal contraceptive or the administering of an injectable hormonal contraceptive under this chapter. (B) A pharmacist who dispenses a self-administered hormonal contraceptive or administers an injectable hormonal contraceptive in accordance with the provisions of this article is not as a result of an act or omission subject to civil or criminal liability or to professional disciplinary action.

Legislative History

HISTORY: 2022 Act No. 210 (S.628), SECTION 2, eff November 16, 2022. Editor's Note 2022 Act No. 210, SECTIONS 1, 4, and 6, provide as follows: "SECTION 1. This act shall be referred to as the 'Pharmacy Access Act'." "SECTION 4. The Board of Medical Examiners and the Board of Pharmacy must issue a written joint protocol pursuant to Section 40-43-240 not later than six months after the passage of this act." "SECTION 6. Except as otherwise specifically provided, this act takes effect upon the issuance of a written joint protocol pursuant to SECTION 4 of this act." The written joint protocol was issued on November 16, 2022.